Medical industry, you wish to carry out an analysis of particulate contamination in injectables
What is an injectable?
First of all, an injectable product is a drug in the form of a gel or solution that is injected into the body by the parenteral route, i.e. by intravenous, intramuscular, intradermal or subcutaneous injections.
Thus, injectable drugs are administered with specific equipment such as syringes.
This type of administration allows for an exact dosage of a product without digestive modification. The action of an injected drug is also faster than by enteral route.
Why perform an analysis of particulate contamination in injectables?
Injectable products are subject to particular attention with regard to the risk of contamination. The objective is to guarantee safety throughout the manufacturing process by verifying the absence of particulate contamination in injectable products. Indeed, particulate contamination can be caused by the appearance of abnormal endogenous particles such as glass particles. The appearance of particulate contamination is a problem that can lead to the withdrawal of the injectable solution or the non-authorization of the marketing.
Therefore, the support of a laboratory competent in the analysis of particulate contamination in injectables is indispensable in the framework of a quality control or an injectable development process.
FILAB assists you in your needs for analysis of particulate contamination in injectables
Through our three levels of services: analysis, expertise and R&D support, FILAB assists companies in the medical industry with their needs for analysis of particulate contamination in injectables. FILAB provides its customers with the know-how and experience of its team, as well as a 2100m² analytical park equipped with state-of-the-art equipment.
our services
Separative analytical techniques such as GC-MS or LC-MS
ICP technique (ICP/AES and ICP/MS)
Infrared coupled optical microscopy (µ-FTIR)
